144 related articles for article (PubMed ID: 38398589)
1. Synthesis and In Vitro Antitumor Activity Evaluation of Gefitinib-1,2,3-Triazole Derivatives.
Liu Z; Liu J; Gao E; Mao L; Hu S; Li S
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398589
[TBL] [Abstract][Full Text] [Related]
2. Discovery of gefitinib-1,2,3-triazole derivatives against lung cancer via inducing apoptosis and inhibiting the colony formation.
Gao E; Wang Y; Fan GL; Xu G; Wu ZY; Liu ZJ; Liu JC; Mao LF; Hou X; Li S
Sci Rep; 2024 Apr; 14(1):9223. PubMed ID: 38649732
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-proliferation activity of mogrol derivatives bearing quinoline and triazole moieties.
Song JR; Li N; Li DP
Bioorg Med Chem Lett; 2021 Jun; 42():128090. PubMed ID: 33964443
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
5. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of homoerythrina alkaloid derivatives bearing a triazole moiety as PARP-1 inhibitors and as potential antitumor drugs.
Li S; Li XY; Zhang TJ; Kamara MO; Liang JW; Zhu J; Meng FH
Bioorg Chem; 2020 Jan; 94():103385. PubMed ID: 31669094
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives.
Ghanaat J; Khalilzadeh MA; Zareyee D
Mol Divers; 2021 Feb; 25(1):223-232. PubMed ID: 32067134
[TBL] [Abstract][Full Text] [Related]
8. Novel benzimidazole-triazole hybrids as apoptosis inducing agents in lung cancer: Design, synthesis,
Sridhar Goud N; Pooladanda V; Muni Chandra K; Lakshmi Soukya PS; Alvala R; Kumar P; Nagaraj C; Dawn Bharath R; Qureshi IA; Godugu C; Alvala M
Bioorg Chem; 2020 Sep; 102():104125. PubMed ID: 32738568
[TBL] [Abstract][Full Text] [Related]
9. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
[TBL] [Abstract][Full Text] [Related]
10. SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.
Moody TW; Chan DC; Mantey SA; Moreno P; Jensen RT
Life Sci; 2014 Mar; 100(1):25-34. PubMed ID: 24496038
[TBL] [Abstract][Full Text] [Related]
11. Novel compound ZCJ14, a gefitinib analog, exhibited prominent anti-cancer effect among several cancer cell lines.
Wang J; Yan PP; Wang HY; Zuo SJ; Zhang SQ; Cao YX; Cao L
Life Sci; 2022 Oct; 307():120875. PubMed ID: 35963298
[TBL] [Abstract][Full Text] [Related]
12. New 2-alkoxycyanopyridine derivatives as inhibitors of EGFR, HER2, and DHFR: Synthesis, anticancer evaluation, and molecular modeling studies.
Hawas SS; El-Sayed SM; Elzahhar PA; Moustafa MA
Bioorg Chem; 2023 Dec; 141():106874. PubMed ID: 37769524
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, activity evaluation, and pro-apoptotic properties of novel 1,2,4-triazol-3-amine derivatives as potent anti-lung cancer agents.
Sun XY; Zhong CY; Qiu QQ; Li ZW; Liu MY; Wang X; Jin CH
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1210-1217. PubMed ID: 31286781
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers.
Wang C; Xu S; Peng L; Zhang B; Zhang H; Hu Y; Zheng P; Zhu W
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):203-217. PubMed ID: 30835140
[TBL] [Abstract][Full Text] [Related]
15. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
[TBL] [Abstract][Full Text] [Related]
16. Anti-Lung Cancer Activities of 1,2,3-Triazole Curcumin Derivatives via Regulation of the MAPK/NF-κB/STAT3 Signaling Pathways.
Zhi TX; Liu KQ; Cai KY; Zhao YC; Li ZW; Wang X; He XH; Sun XY
ChemMedChem; 2022 Feb; 17(3):e202100676. PubMed ID: 34773680
[TBL] [Abstract][Full Text] [Related]
17. Characterization of novel heterocyclic compounds based on 4-aryl-4H-chromene scaffold as anticancer agents: Design, synthesis, antiprofilerative activity against resistant cancer cells, dual β-tubulin/c-Src inhibition, cell cycle arrest and apoptosis induction.
Abdelall EKA; A H Elshemy H; Labib MB; E A Mohamed F
Bioorg Chem; 2022 Mar; 120():105591. PubMed ID: 34998122
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel uracil derivatives bearing 1, 2, 3-triazole moiety as thymidylate synthase (TS) inhibitors and as potential antitumor drugs.
Lu GQ; Li XY; Mohamed O K; Wang D; Meng FH
Eur J Med Chem; 2019 Jun; 171():282-296. PubMed ID: 30927565
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative evaluation of novel 2-(4H-1,2,4-triazole-3-ylthio)acetamide derivatives as inducers of apoptosis in cancer cells.
Kulabaş N; Tatar E; Bingöl Özakpınar Ö; Özsavcı D; Pannecouque C; De Clercq E; Küçükgüzel İ
Eur J Med Chem; 2016 Oct; 121():58-70. PubMed ID: 27214512
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel diaryl urea derivatives bearing a triazole moiety as potential antitumor agents.
Qin M; Yan S; Wang L; Zhang H; Zhao Y; Wu S; Wu D; Gong P
Eur J Med Chem; 2016 Jun; 115():1-13. PubMed ID: 26991938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
